<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04184336</url>
  </required_header>
  <id_info>
    <org_study_id>MENING</org_study_id>
    <nct_id>NCT04184336</nct_id>
  </id_info>
  <brief_title>Enhanced Population-based Core Surveillance of Meningococcal Invasive Infections at Participating Centers Across Canada</brief_title>
  <official_title>IMPACT Project Protocol: Enhanced Population-based Core Surveillance of Meningococcal Invasive Infections at Participating Centers Across Canada</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Canadian Paediatric Society</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Pfizer</agency>
      <agency_class>Industry</agency_class>
    </collaborator>
    <collaborator>
      <agency>GlaxoSmithKline</agency>
      <agency_class>Industry</agency_class>
    </collaborator>
  </sponsors>
  <source>Canadian Paediatric Society</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Active metropolitan area surveillance for hospital admissions related to invasive infection
      with Neisseria meningitidis will be conducted at the 12 centers in the IMPACT network in
      collaboration with Public Health officials, local infection specialists and infection control
      practitioners during the interval from January 1, 2016 to December 31, 2020.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The objectives are 3-fold, including:

        1. description of affected children and adults and the nature and outcome of the infection
           episodes

        2. incidence rate determination in defined populations, by age, serogroup and study year

        3. detailed study of the organisms recovered from cases
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">January 2016</start_date>
  <completion_date type="Anticipated">December 2020</completion_date>
  <primary_completion_date type="Anticipated">December 2020</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Other</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Laboratory confirmed invasive meningococcal cases.</measure>
    <time_frame>up to 2020</time_frame>
    <description>Laboratory confirmed invasive meningococcal cases.</description>
  </primary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Anticipated">400</enrollment>
  <condition>Invasive Meningococcal Disease</condition>
  <arm_group>
    <arm_group_label>Persons of all ages</arm_group_label>
    <description>Persons of all ages admitted between January 1, 2016 and December 31, 2020 with a positive result of Neisseria meningitidis isolated or detected by PCR from a normal sterile site, such as blood, CSF, joint fluid, pleural, peritoneal, pericardial fluid or tissue biopsy</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>surveillance</intervention_name>
    <arm_group_label>Persons of all ages</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Any person admitted with confirmation of an invasive meningococcal infection at all
        participating Centers across Canada
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:Neisseria meningitidis isolated or detected by PCR from a normally
        sterile body site or fluid, such as blood, CSF, joint fluid, pleural, peritoneal,
        pericardial fluid or tissue biopsy -

        Exclusion Criteria:patients diagnosed based only on

          1. clinical signs, gram stain, or antigen test

          2. meningococci isolated only from respiratory tract, including conjunctiva, sinuses,
             middle ear/mastoid, throat, peritonsillar abscess, cervical lymph node, tracheal
             aspirate, bronchial lavage etc -
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Melanie Laffin Thibodeau</last_name>
    <phone>613-526-9397</phone>
    <phone_ext>239</phone_ext>
    <email>melaniel@cps.ca</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Marie Adele Davis</last_name>
    <phone>613-526-9397</phone>
    <email>madavis@cps.ca</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Alberta Children's Hospital</name>
      <address>
        <city>Calgary</city>
        <state>Alberta</state>
        <zip>T3B 6A8</zip>
        <country>Canada</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Taj Jadavji, MD</last_name>
    </contact>
    <investigator>
      <last_name>Taj Jadavji, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Stollery Children's Hospital</name>
      <address>
        <city>Edmonton</city>
        <state>Alberta</state>
        <zip>T6G 1C9</zip>
        <country>Canada</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Wendy Vaudry, MD</last_name>
    </contact>
    <investigator>
      <last_name>Wendy Vaudry, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>BC Children's Hospital</name>
      <address>
        <city>Vancouver</city>
        <state>British Colombia</state>
        <zip>V5Z 4H4</zip>
        <country>Canada</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Manish Sadarangani</last_name>
    </contact>
    <investigator>
      <last_name>Manish Sadarangani, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Children's Hospital Research Institute of Manitoba</name>
      <address>
        <city>Winnipeg</city>
        <state>Manitoba</state>
        <zip>R3E 3P4</zip>
        <country>Canada</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Joanne Embree, MD</last_name>
    </contact>
    <investigator>
      <last_name>Joanne Embree, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Eastern Health Janeway Children's and Rehabilitation Centre</name>
      <address>
        <city>Saint John's</city>
        <state>Newfoundland and Labrador</state>
        <zip>A1B 3V6</zip>
        <country>Canada</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Natalie Bridger, MD</last_name>
    </contact>
    <investigator>
      <last_name>Natalie Bridger, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>IWK Health Centre</name>
      <address>
        <city>Halifax</city>
        <state>Nova Scotia</state>
        <zip>B3K6R8</zip>
        <country>Canada</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Karina Top, MD</last_name>
    </contact>
    <investigator>
      <last_name>Karina Top, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Children's Hospital of Eastern Ontario</name>
      <address>
        <city>Ottawa</city>
        <state>Ontario</state>
        <zip>K1H 8L1</zip>
        <country>Canada</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Nicole Le Saux, MD</last_name>
    </contact>
    <investigator>
      <last_name>Nicole Le Saux, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>The Hospital for Sick Children</name>
      <address>
        <city>Toronto</city>
        <state>Ontario</state>
        <zip>M5G 1X8</zip>
        <country>Canada</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Shaun Morris, MD</last_name>
    </contact>
    <investigator>
      <last_name>Shaun Morris</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>CHU- Sainte Justine</name>
      <address>
        <city>Montr√©al</city>
        <state>Quebec</state>
        <zip>H3T 1C5</zip>
        <country>Canada</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Marc Lebel, MD</last_name>
    </contact>
    <investigator>
      <last_name>Marc Lebel, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Montreal Children's Hospital</name>
      <address>
        <city>Montr√©al</city>
        <state>Quebec</state>
        <zip>H4A 3J1</zip>
        <country>Canada</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Jesse Papenburg, MD</last_name>
    </contact>
    <investigator>
      <last_name>Jesse Papenburg, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Centre Mere-Enfant Soleil CHU de Quebec</name>
      <address>
        <city>Qu√©bec</city>
        <state>Quebec</state>
        <zip>G1V 4G2</zip>
        <country>Canada</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Roseline Thibeault, MD</last_name>
    </contact>
    <investigator>
      <last_name>Roseline Thibeault</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Royal University Hospital</name>
      <address>
        <city>Saskatoon</city>
        <state>Saskatchewan</state>
        <zip>S7N 0W8</zip>
        <country>Canada</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Ben Tan</last_name>
    </contact>
    <investigator>
      <last_name>Ben Tan, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Canada</country>
  </location_countries>
  <link>
    <url>http://www.cps.ca/en/impact</url>
    <description>Description IMPACT public website</description>
  </link>
  <verification_date>December 2019</verification_date>
  <study_first_submitted>November 28, 2019</study_first_submitted>
  <study_first_submitted_qc>November 28, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">December 3, 2019</study_first_posted>
  <last_update_submitted>December 3, 2019</last_update_submitted>
  <last_update_submitted_qc>December 3, 2019</last_update_submitted_qc>
  <last_update_posted type="Actual">December 5, 2019</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Meningococcal Infections</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

